Perrigo | PRGO - Current Liabilities


Perrigo reported $997.6M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
AbbVie USD 41.64B 458M Jun/2026
Abbott USD 18.38B 1.88B Mar/2026
Bayer EUR 33.46B 875M Mar/2026
Bristol-Myers Squibb USD 18.66B 499M Jun/2026
Coherus Biosciences USD 140.39M 231.91M Dec/2025
Corcept Therapeutics USD 153.8M 4.62M Jun/2026
Dr.Reddys Laboratories INR 157.34B 10.13B Jun/2026
Eli Lilly USD 36.63B 1.41B Mar/2026
J&J USD 54.9B 2.82B Jun/2026
Merck USD 26.94B 1.38B Mar/2026
Nestle CHF 45.29B 4.6B Jun/2026
Pacira USD 122.01M 13.22M Jun/2026
Perrigo USD 997.6M 15.3M Mar/2026
Pfizer USD 32.65B 1.7B Jun/2026
Phibro Animal Health USD 281.87M 500K Mar/2026
Prestige Brands USD 120.92M 18.63M Mar/2026
Reckitt Benckiser GBP 7.94B 901M Dec/2024
Sanofi EUR 31.93B 1.92B Jun/2026
Supernus Pharmaceuticals USD 347.38M 26.55M Jun/2026
Teva Pharmaceutical Industries USD 15.65B 2.11B Jun/2026
Xeris Pharmaceuticals USD 118.59M 9.02M Mar/2026
Zoetis USD 2.05B 182M Mar/2026